Grantham, Mayo, Van Otterloo & Co (GMO)’s iShares Core MSCI International Developed Markets ETF IDEV Stock Holding History
Bought
Maintained
Sold
Other funds holding IDEV
BOK
RBA
Grantham, Mayo, Van Otterloo & Co (GMO)'s IDEV Position: Q1 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) reduced its iShares Core MSCI International Developed Markets ETF (IDEV) stake by 55% in Q1 2026, selling an estimated $664K and leaving 6,236 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #552.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in IDEV in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.15M in Q4 2025. 706 funds tracked by Wall St. Rank hold IDEV as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 6,236 shares of iShares Core MSCI International Developed Markets ETF worth $521K as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 7,723 iShares Core MSCI International Developed Markets ETF shares in Q1 2026, an estimated $664K.
- iShares Core MSCI International Developed Markets ETF made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #552 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in iShares Core MSCI International Developed Markets ETF in Q4 2025 and has held it in 2 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s iShares Core MSCI International Developed Markets ETF position peaked at $1.15M in Q4 2025.
- 706 funds tracked by Wall St. Rank held iShares Core MSCI International Developed Markets ETF as of Q1 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.